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evelopment of oligodendrocytes and the generation
of myelin internodes within the spinal cord depends
on regional signals derived from the notochord and
axonally derived signals. Neuregulin 1 (NRG)-1, localized
 
in the ﬂoor plate as well as in motor and sensory neurons,
is necessary for normal oligodendrocyte development.
Oligodendrocytes respond to NRGs by activating members
 
of the erbB receptor tyrosine kinase family. Here, we show
that erbB2 is not necessary for the early stages of oligodendro-
cyte precursor development, but is essential for proligoden-
droblasts to differentiate into galactosylcerebroside-positive
(GalC
 
 
 
) oligodendrocytes. In the presence of erbB2, oligo-
dendrocyte development is normal. In the absence of
D
 
erbB2 (erbB2
 
 
 
/
 
 
 
), however, oligodendrocyte development
is halted at the proligodendroblast stage with a 
 
 
 
10-fold
 
reduction in the number of GalC
 
 
 
 oligodendrocytes. ErbB2
appears to function in the transition of proligodendroblast to
oligodendrocyte by transducing a terminal differentiation
signal, since there is no evidence of increased oligodendro-
cyte death in the absence of erbB2. Furthermore, known
survival signals for oligodendrocytes increase oligodendro-
cyte numbers in the presence of erbB2, but fail to do so in
the absence of erbB2. Of the erbB2
 
 
 
/
 
 
 
 oligodendrocytes
that do differentiate, all fail to ensheath neurites. These data
suggest that erbB2 is required for the terminal differentiation
of oligodendrocytes and for development of myelin.
 
Introduction
 
Development of oligodendrocytes capable of forming my-
elin internodes requires several distinct environmental cues.
These include early, regional, and later axonally derived sig-
nals. The initial specification of spinal cord oligodendrocyte
precursor cells (OPCs)* is dependent on signals from ventral
structures, such as the notochord and floor plate (Warf et
al., 1991; Noll and Miller, 1993; Yu et al., 1994; Ono et al.,
1995; Timsit et al., 1995). For example, notochord ablation
delays OPC appearance, and notochord transplantation in-
duces adjacent ectopic OPCs (Pringle et al., 1996; Orentas
et al., 1999). One critical signaling molecule in early OPC
specification appears to be Sonic hedgehog derived from
floor plate and notochord (Pringle et al., 1996; Orentas et
al., 1999), which induces the basic helix–loop–helix mole-
cules olg-1 and olg-2 (Lu et al., 2000; Zhou et al., 2000).
After their initial appearance in the ventral ventricular zone
(Noll and Miller, 1993; Timsit et al., 1995), OPCs migrate
widely throughout the neuraxis (Warrington et al., 1993),
mature through antigenically and morphologically distinct
stages, and ultimately form myelin internodes. An early
stage of OPC is an mAb A2B5 immunoreactive, bipolar
(Raff et al., 1983), motile cell (Small et al., 1987; Noble et
al., 1988; Armstrong et al., 1991; Osterhout et al., 1997;
Simpson and Armstrong, 1999) with a mitogenic response
to PGDF-AA and bFGF (Noble et al., 1988; Raff et al.,
1988; Bogler et al., 1990; Gard and Pfeiffer, 1990; McKin-
non et al., 1990). These A2B5
 
 
 
 cells mature into proligo-
dendroblasts, less-motile cells (Warrington et al., 1993)
(characterized by surface labeling with the O4 mAb, but
not antigalactosylcerebroside antibodies; Gard and Pfeiffer,
1990), and a fine arbor of processes. Proligodendroblasts
proliferate in response to a different spectrum of mitogens
from A2B5
 
 
 
/O4
 
 
 
 cells (Gard and Pfeiffer, 1990). Differ-
entiation of proligodendroblasts is accompanied by exit
from the cell cycle (Hart et al., 1989; Gard and Pfeiffer,
1990) and acquisition of galactosylcerebroside expression
(Raff et al., 1978; Sommer and Schachner, 1981), identified
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by mAb O1. Before axonal ensheathment and myelination,
oligodendrocytes mature and express myelin genes such as
myelin basic protein (MBP) (Sternberger et al., 1978). Ma-
turing oligodendrocytes undergo progressive remodeling of
their process arbor (Hardy and Friedrich, 1996) during a
dramatic but poorly understood metamorphosis from pre-
myelinating to myelinating cells. The multiple distinct steps
in oligodendrocyte and myelin formation are regulated by
distinct signaling systems. Although some of these signaling
systems are beginning to be understood, control of the later
stages in myelin formation is still poorly understood.
Axonally derived signals appear to be required for several
aspects of oligodendrocyte and myelin formation (for review
see Barres and Raff, 1999). One potential axonally derived
signaling molecule critical for oligodendrocyte and myelin
formation is neuregulin (NRG)-1 (for review see Carraway
and Burden, 1995; Pinkas-Kramarski et al., 1998; Riese and
Stern, 1998; Adlkofer and Lai, 2000). In serially passaged
OPCs, NRG is mitogenic (Canoll et al., 1996, 1999). Like-
wise, in conjunction with cAMP and/or PDGF, NRG pro-
motes proliferation of optic nerve OPCs (Shi et al., 1998). In
long-term cultures of OPCs (“aged OPCs”), NRG trans-
duces a potent survival signal (Fernandez et al., 2000; Flores
et al., 2000) mediated through the Akt pathway (Flores et al.,
2000), whereas in vivo inhibitors of NRG significantly re-
duce the number of optic nerve OPCs (Fernandez et al.,
2000). By contrast, in low-density cultures of primary fore-
brain oligodendrocytes, NRG promotes cell spreading and
process extension (Vartanian et al., 1994; Raabe et al., 1997).
In spinal cord explants bearing a loss-of-function mutation in
the NRG-1 gene, O4
 
 
 
 proligodendroblasts completely fail
to develop (Vartanian et al., 1999). This early defect in oligo-
dendrocyte development in NRG-1 mutants can be reversed
by the addition of recombinant NRG (Vartanian et al.,
1999). Consistent with a role for NRGs during early devel-
opment of the oligodendrocyte lineage, early ventral struc-
tures such as the ventral ventricular zone and floor plate of
the spinal cord (Vartanian et al., 1999) and the subventricu-
lar zone of the forebrain (Vartanian et al., 1994; Corfas et al.,
1995) express NRG at the time that OPCs initially arise.
Multiple factors dictate the cellular effects of NRG. These
include the specific ligand, levels and repertoire of receptor ex-
pression, and the cellular context. The large number of NRG
ligands arise from four known genes with multiple splice and
promoter variants (for review see Fischbach and Rosen, 1997;
Adlkofer and Lai, 2000). In some cases, splice variants such as
the cysteine-rich domain isoform have been shown to be re-
quired for specific aspects of nervous system development
(Wolpowitz et al., 2000). Receptor usage is relatively restricted
for the ligands EGF (to erbB1) and NRG-4 (to erbB4) and rel-
atively broad for NRG-1 (erbB2, erbB3, and erbB4) (for re-
view see Yarden and Sliwkowski, 2001). Signal transduction
through erbB receptors occurs as the consequence of essential
ligand-induced receptor dimerizations. For example, erbB2
lacks a binding site for NRG, whereas erbB3 lacks intrinsic ty-
rosine kinase activity, and neither can transduce NRG signals
in isolation (Riese and Stern, 1998; Yarden and Sliwkowski,
2001). By contrast, erbB4 is both capable of binding ligand
and possesses an intact tyrosine kinase domain (Riese and
Stern, 1998; Yarden and Sliwkowski, 2001). Although erbB3
or erbB4 will bind ligand alone, heterodimerization with erbB2
 
increases the affinity of the receptor complex for its ligand
 
 
 
14-fold (Sliwkowski et al., 1994). ErbB2 appears to be the
preferred receptor partner in most, if not all, erbB heterodimers
(Graus-Porta et al., 1997), and it increases the complexity of
signal transduction after NRG stimulation (Pinkas-Kramarski
et al., 1997; Riese and Stern, 1998; Yarden and Sliwkowski,
2001). Furthermore, unique and overlapping docking sites for
adapter proteins and cytosolic enzymes exist for individual
erbBs, making them capable of transducing both common and
distinct signals (Plowman et al., 1993; Wang et al., 1998a;
Jones et al., 1999). The cellular context of NRG–receptor in-
teractions is also critical for determining cellular responses. For
example, neural crest cells, Schwann cell precursors, and
Schwann cells all express erbB2 and erbB3 receptors for NRG.
In multipotent crest cells, NRG-1 specifies a glial fate (Shah
et al., 1994) and in Schwann cell precursors, NRG-1 speci-
fies survival (Dong et al., 1995), while in Schwann cells
NRG-1 specifies proliferation (Dong et al., 1995; Morrissey
et al., 1995).
Here we examine the requirement for erbB2 signaling
during development of the spinal cord oligodendrocyte lin-
eage. Through a targeted disruption of the murine erbB2
gene, we demonstrate that, in striking contrast to the ab-
sence of NRG-1, the absence of erbB2 has no effect on the
formation of the early oligodendrocyte lineage. However,
ErbB2 does appear to be essential for normal development
of later stages of the oligodendrocyte lineage. In the absence
of erbB2, the development of differentiated O1
 
 
 
 oligoden-
Figure 1. Targeted disruption of the murine erbB2 gene. (A) Sche-
matic representation of the 1,260 amino acid erbB2/neu protein 
(top) and the 13-kb genomic fragment (bottom) used to generate the 
targeting construct. The shaded 2.8-kb region represents the 
genomic fragment containing the exon encoding the essential 
transmembrane domain of the erbB2 receptor protein, as well as 
flanking sequences encoding parts of the extracellular and cytoplasmic 
domains, replaced by the neo
r cassette. (B) Southern blot analysis of 
HindIII-restricted genomic DNA probed with a cDNA fragment 
found outside the targeting construct. (C) Western blot analysis of 
10.5 dpc embryos homogenized in SDS-PAGE buffer, resolved by 
5% SDS-PAGE, and probed for erbB2. 
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drocytes was dramatically deficient. In addition, the limited
O1
 
 
 
 oligodendrocytes that develop in the absence of erbB2
signaling failed to ensheath neurites and form myelin in
long-term cultures. These findings are analogous to those in
the peripheral nervous system (PNS), in which an erbB2/
Schwann cell conditional mutant (Krox20-cre/
 
 
 
; erbB2
 
flox
 
/
 
 
 
) shows reduced numbers of Schwann cell precursors and
deficient PNS myelination (Garratt et al., 2000). The inhi-
bition of oligodendrocyte differentiation in the absence of
erbB2 appears lineage-specific, since the lack of erbB2 did
not quantitatively effect astrocyte development or the extent
of neurite outgrowth. Our data suggest that distinct receptor
combinations are used by cells of the oligodendrocyte lin-
eage to transduce NRG signals at distinct stages in develop-
ment. Interestingly, Canoll et al. (1996, 1999) observed an
increase in erbB2 expression as oligodendrocytes differenti-
ate from OPCs. Although erbB2 signaling is not required
during early OPC development, our findings suggest it is es-
sential for later oligodendrocyte differentiation and the ef-
fective genesis of the myelin internode.
 
Results
 
Targeted disruption of the murine erbB2 gene
 
To determine the importance of erbB2 in oligodendrocyte
development, a loss-of-function mutation in the erbB2 gene
 
was generated. To construct a targeting vector, the mouse
erbB2 gene was cloned from a 129/SvJ genomic library and
the PGK-1–driven neomycin resistance cassette was inserted
to replace a 2–3-kb fragment containing the exon encoding
the essential transmembrane domain of erbB2, as well as
flanking sequences encoding portions of the extracellular
and cytosolic domains (Fig. 1 A). After transfection and se-
lection of embryonic stem (ES) cells, ES cell clones bearing
the disrupted erbB2 gene were identified by Southern analy-
sis and injected into C57BL/6 blastocysts. Chimeric founder
mice were able to pass the disrupted allele through the germ
line (Fig. 1 B). Homozygous null mutants failed to develop
past 11.5 d postconception (dpc), as reported previously by
Lee et al. (1995), and apparently express no full-length
erbB2 (Fig. 1 C), whereas heterozygous animals developed
normally and expressed approximately half the wild-type
levels of erbB2 (Fig. 1 C).
 
Oligodendrocytes express erbB2, erbB3, and erbB4
 
Our previous studies suggested oligodendrocytes expressed
erbB2 and erbB4 but not erbB3 receptors, whereas
Schwann cells expressed erbB2 and erbB3 and astrocytes
expressed all three receptors (Vartanian et al., 1997).
However, others have shown that oligodendrocytes ex-
press erbB3 as well as erbB2 and erbB4 (Canoll et al.,
1996, 1999). To reconcile these differences in the re-
Figure 2. Developing spinal cord oligodendrocytes 
express the NRG receptors erbB2, erbB3, and erbB4. 
(A) RT-PCR of erbB2 (B2), erbB3 (B3), and erbB4 (B4) 
fragments from immunopanned OPC and oligoden-
drocyte total RNA. A2B5 /O4  OPCs or O4  oligo-
dendrocytes were immunopanned from newborn rat 
spinal cord using cell surface–specific antibodies, and 
then used directly for isolation of total RNA. Using 
receptor-specific primer pairs, mRNAs encoding each 
receptor were identified. (B) Immunostaining of OPCs 
and oligodendrocytes for erbB2, erbB3, and erbB4. 
OPCs and oligodendrocytes purified from rat forebrain 
mixed glia were cultured for 2 d in PDGF and bFGF to 
study OPCs, or for an additional 2 d in the absence of 
these growth factors (in the presence of N2 additives) 
to study O4  oligodendrocytes. Both stages in the 
lineage express the NRG receptors erbB2, erbB3, and 
erbB4 throughout their soma and processes, although 
levels of erbB3 expression are less than erbB2 and 
erbB4. Bar, 30  m. 
1248 The Journal of Cell Biology 
 
|
 
 
 
Volume 154, Number 6, 2001
 
ported repertoire of erbB receptor expression in oligoden-
drocytes, purified cells from different stages of the rat spi-
nal cord oligodendrocyte lineage were assayed by reverse
transcriptase (RT)-PCR and immunostaining using im-
proved antibodies to erbB3. Immunopan-purified OPCs,
as well as oligodendrocytes, expressed erbB2, erbB3, and
erbB4 transcripts by RT-PCR, and the levels appeared
equivalent between these two stages of development (Fig.
2 A). To determine whether mouse OPCs and oligoden-
drocytes expressed detectable levels of erbB receptor pro-
tein, purified forebrain OPCs and oligodendrocytes were
double-labeled with erbB and oligodendrocyte-specific an-
tibodies. ErbB2 and erbB4 were strongly detected on
OPCs, whereas the expression levels of erbB3 were lower
(Fig. 2 B). These data, in contrast to our earlier studies,
suggest that both OPCs and oligodendrocytes express
mRNA and protein for erbB2, erbB3, and erbB4, all of
which may contribute to NRG signaling.
 
A specific requirement of erbB2 for the transition from 
proligodendroblasts to oligodendrocytes
 
To determine if erbB2 plays a specific role in oligodendro-
cyte development, spinal cord explant cultures from em-
bryonic day (E)9.5 mouse embryos, which were the prod-
 
uct of erbB2
 
 
 
/
 
 
 
 matings, were prepared. E9.5 was selected
for obtaining embryos, as it was 2 d before any observable
loss of viability in erbB2
 
 
 
/
 
 
 
 embryos. Explants from indi-
vidual spinal cords were cultured in single wells on a poly-
lysine/laminin substrate. Genotyping of the embryos was
carried out concurrently, but results were kept blinded un-
til the scoring of oligodendrocyte development in the ex-
plant cultures was completed. Spinal cord explants grown
for 10 d were labeled with either mAb O4 to detect proli-
godendroblasts and oligodendrocytes or O1 to detect dif-
ferentiated oligodendrocytes. This explant culture para-
digm has been shown previously to faithfully replicate
oligodendrocyte development in vivo with the appearance
of O4
 
 
 
/O1
 
 
 
 proligodendroblasts at the equivalent of
E15, and O4
 
 
 
/O1
 
 
 
 oligodendrocytes by E17 (Fok and
Miller, 1994). In spinal cord explants from erbB2
 
 
 
/
 
 
 
,
erbB2
 
 
 
/
 
 
 
, and erbB2
 
 
 
/
 
 
 
 embryos cultured for 10 d (equiv-
alent to E20), development of the oligodendrocyte lineage
to the O4
 
 
 
 stage appears normal and essentially indistin-
guishable in all three genotypes. By contrast, the number of
O1
 
 
 
-differentiated oligodendrocytes was dramatically re-
duced in explants derived from erbB2
 
 
 
/
 
 
 
 spinal cords com-
pared with wild-type and erbB2
 
 
 
/
 
 
 
-derived explants (Fig. 3
A). Quantitative analyses of O1
 
 
 
 oligodendrocytes dem-
Figure 3. Severe loss of O1  oligodendrocytes in 
the absence of erbB2. (A) Development of O4  
oligodendrocytes is normal in the presence of erbB2 
(erbB2
 / ), as well as in its absence (erbB2
 / ). The 
absence of erbB2 results in a severe loss of O1  
oligodendrocytes. Spinal cord explants from E9.5 
mouse embryos were cultured for 10 d before fixation 
and assessment of oligodendrocyte development. 
(B) Quantitative analysis of explant data reveals a 
 10-fold reduction in the number of O1  oligoden-
drocytes in the absence of erbB2 compared with 
erbB2
 /  and erbB2
 /  explants. Results are presented 
as  SEM and comparisons by ANOVA are significant 
at P   0.0001 (indicated by asterisks). (C) Quantitative 
analysis of MBP  oligodendrocytes shows results 
similar to those for O1. Spinal cord explants from E9.5 
embryos were cultured for  30 d before fixation. 
In the absence of erbB2, the number of MBP  oligo-
dendrocytes is reduced by an order of magnitude. 
(D) The defect in erbB2 loss-of-function mutants is 
sustained throughout late stages of oligodendrocyte 
development. Similar to results for O1, there is a 
severe loss of MBP  oligodendrocytes in the absence 
of erbB2. Bars, 100  m. 
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onstrated that wild-type and erbB2
 
 
 
/
 
 
 
 spinal cord explants
contained a similar number of differentiated oligodendro-
cytes after 10 d in vitro. Wild-type–derived explants con-
tained 
 
 
 
216 O1
 
 
 
 cells (
 
n
 
 
 
 
 
 50 explants), whereas het-
erozygote-derived explants contained 
 
 
 
202 (
 
n
 
 
 
 
 
 60) O1
 
 
 
cells/explant (Fig. 3 B). In parallel spinal cord explants de-
rived from erbB2
 
 
 
/
 
 
 
 littermates, the number of O1
 
 
 
 oli-
godendrocytes was dramatically diminished. Homozygote
(erbB2
 
 
 
/
 
 
 
) -derived explants contained 
 
 
 
18 O1
 
 
 
 cells/ex-
plant (
 
n
 
 
 
 
 
 46) (Fig. 3 B). The small number of O1
 
 
 
 oli-
godendrocytes in erbB2
 
 
 
/
 
 
 
-derived explants appeared via-
ble and were retained when the explants were maintained
for 
 
 
 
30 d (see below). These data suggest that erbB2 trans-
duces a signal that is not required for the development of
the oligodendrocyte lineage before and including O4
 
 
 
precursors, but is necessary for the subsequent appearance
of O1
 
 
 
-differentiated oligodendrocytes.
Before myelination, oligodendrocytes undergo extensive
remodeling of their process arbor (Hardy and Friedrich,
1996) and begin to express genes of myelination such as
MBP. If erbB2 signaling was required for progression from
O4
 
 
 
/O1
 
 
 
 proligodendroblasts to O4
 
 
 
/O1
 
 
 
 oligoden-
drocytes, the number of cells expressing myelination genes
such as MBP should also be significantly diminished in the
absence of erbB2. To test this hypothesis, spinal cord ex-
plants from E9.5 wild-type, erbB2
 
 
 
/
 
 
 
, and erbB2
 
 
 
/
 
 
 
 em-
bryos were grown for 30 d, (to the equivalent of approxi-
mately P20) and the number of MBP
 
 
 
 oligodendrocytes
were compared. Explants derived from wild-type and
erbB2
 
 
 
/
 
 
 
 embryos contained 10–12 times the number of
MBP  oligodendrocytes compared with erbB2
 /  explants
(Fig. 3, C and D). This result is consistent with the hypoth-
esis that erbB2 is required for development of differentiated
O1  oligodendrocytes.
A predominant role for ErbB2 in oligodendrocyte 
development: neurite outgrowth and astrocyte 
development appear normal in the absence of erbB2
Other neural cell types express erbB receptors (Pinkas-Kra-
marski et al., 1994; Corfas et al., 1995). To test whether
erbB2 was required for the differentiation of all neural cell
types, spinal cord explants from E9.5 wild-type, erbB2
 / ,
and erbB2
 /  embryos were assayed for neurite outgrowth
and astrocyte development after 10 d in vitro. Explants were
fixed and stained with antibodies to neurofilament (NF) to
detect neurites, or to glial fibrilary acidic protein (GFAP) to
detect astrocytes. Neurite outgrowth was extensive and com-
parable in explants from wild-type, erbB2
 / , and erbB2
 / 
embryos (Fig. 4). Astrocytes express the NRG receptors
erbB2, erbB3, and erbB4 (Pinkas-Kramarski et al., 1994;
Vartanian et al., 1997); however, in contrast to the effects on
the oligodendrocyte lineage, the number and morphology of
GFAP  astrocytes appeared similar between wild-type–,
erbB2
 / -, and erbB2
 / -derived explants (Fig. 4). These
data indicate that erbB2 signaling is not essential for astro-
cyte development, although the presence of astrocyte mito-
gens in culture serum supplements may compensate for the
absence of erbB2 signaling. These data suggest that develop-
ment of the oligodendrocyte lineage is most dependent on
erbB2 signaling.
Excess NRG does not rescue development of 
oligodendrocytes in the absence of erbB2
The erbB2 receptor is required for the generation of high
affinity NRG binding sites in erbB2/3 or erbB2/4 het-
erodimers. Although erbB2 is required for high affinity
ligand binding, erbB4 homodimers as well as erbB3/erbB4
Figure 4. The absence of erbB2 does not impact the extent of 
neurite outgrowth or astrocyte development. Spinal cord explants 
from E9.5 embryos were cultured for 10 d in vitro and then studied 
for neurite outgrowth and astrocyte development. Similar results 
were obtained for erbB2
 /  and erbB2
 /  explants and for simplicity 
erbB2
 /  are shown. Neurite outgrowth in erbB2
 /  spinal cord 
explants, assessed by NF staining, was not apparently different from 
erbB2
 /  explants. The quantity and morphology of astrocytes 
assessed by GFAP immunostaining in erbB2
 /  spinal cord explants 
is similar to that of erbB2
 /  explants. Bars: (neurofilament) 20  m; 
(GFAP) 100  m.1250 The Journal of Cell Biology | Volume 154, Number 6, 2001
heterodimers are capable of transducing NRG-mediated sig-
nals (Plowman et al., 1993; Riese et al., 1995; Wang et al.,
1998a). Thus, the effect of the erbB2 loss-of-function muta-
tion on oligodendrocyte development may reflect either a re-
duction in the affinity of the NRG receptor complex for
NRG-1, or a lack of specific intracellular signaling events
dictated by phosphorylation of the erbB2 cytosolic domain.
To determine whether the failure of oligodendrocyte differ-
entiation simply reflected a reduction in the affinity of ligand
binding, spinal cord explants were grown in the presence of
high concentrations of exogenous NRG. Alternating spinal
cord segments from embryos of each genotype were divided
into two groups, one of which received 20 nM NRG (four
times the reported KD of NRG for erbB4 alone; Culouscou
et al., 1993) for the entire culture period, whereas the other
received control vehicle alone. After 10 d, exogenous NRG-1
significantly increased the number of O1  oligodendrocytes
in wild-type and erbB2
 /  explants (Fig. 5). By contrast, ex-
ogenous NRG at supramaximal concentrations did not in-
crease the numbers of O1  oligodendrocytes in explants
from erbB2
 /  embryos (Fig. 5). The NRG-induced in-
crease in oligodendrocytes in erbB2-containing explants sug-
gests that endogenous NRG concentrations are limiting in
normal embryos (Fig. 5) and, in conjunction with our previ-
ous work in the NRG-1 null mutant (Vartanian et al.,
1999), indicates that exogenous NRG has access to explant
cells. The absence of response in explants lacking erbB2 indi-
cates that activation of erbB3/erbB4 alone is not sufficient
for production of O1  oligodendrocytes. This finding sup-
ports the concept that erbB2 generates a specific signal nec-
essary for the appearance of O1  oligodendrocytes.
Lack of erbB2 signaling does not enhance cell death in 
the oligodendrocyte lineage
The lack of differentiated, galactosylcerebroside-positive
(O1 ) oligodendrocytes in explants derived from animals
lacking erbB2 may reflect either the requirement for an
erbB2-specific signal for differentiation or a reduction in a
survival signal. To determine whether erbB2 mediated a spe-
cific survival signal for newly generated oligodendrocytes, the
levels of cell death at different developmental stages of the
oligodendrocyte lineage were compared in explants derived
from embryos of different genotypes. In each case, the total
number of oligodendrocyte lineage cells and the proportion
of apoptotic cells identified by nuclear pyknosis using pro-
pidium iodide labeling (Fig. 6 C) were quantified. Explants
derived from erbB2
 /  embryos showed no increase in the
number of apoptotic O4  proligodendroblasts or differenti-
ated O1  oligodendrocytes compared with those derived
from erbB2
 /  and erbB2
 /  embryos (Fig. 6). Furthermore,
even though erbB2
 / -derived explants contained far fewer
oligodendrocytes, the ratio of apoptotic oligodendrocytes to
total oligodendrocytes did not vary between explants derived
from different erbB genotypes (Table I).
To determine whether known oligodendrocyte lineage
survival factors could compensate for the lack of erbB2 sig-
naling, explants were grown in the presence of exogenous
survival factors not requiring erbB2 for signal transduction.
The best characterized mitogens and survival factors for
newly formed oligodendrocytes are PDGF and leukemia in-
hibitory factor (LIF), each of which activate distinct signal-
ing pathways (Barres et al., 1992a,b; Mayer et al., 1994).
PDGF acts through the PDGF-  receptor in oligodendro-
cyte lineage cells, whereas LIF signals are mediated through
the gp130 cytokine receptor. Explants of embryonic spinal
cords derived from erbB2
 /  matings were grown in the
presence of exogenous PDGF or LIF. In the presence of
PDGF-AA, there was an  30% increase in the number of
O1  oligodendrocytes in erbB2-containing explants com-
pared with controls (Fig. 7 A). These findings are consistent
with the hypothesis that survival and mitogenic factors are at
submaximal concentrations both in vitro and in vivo (Raff et
al., 1998). In explants derived from erbB2
 /  embryos,
there was also a small increase in the number of O1  oligo-
dendrocytes in explants grown in the presence of PDGF
compared with controls (Fig. 7 A). Even in the presence of
exogenous PDGF, however, explants derived from erbB2
 / 
embryos had fewer than one tenth the number of O1  oli-
godendrocytes than erbB2
 /  or erbB2
 /  explants, indicat-
ing that PDGF was unable to compensate for the lack of
erbB2 signaling in the development of spinal cord oligoden-
drocytes. Similar results were obtained with LIF. In the pres-
ence of LIF, the number of O1  oligodendrocytes nearly
doubled in spinal cord explants from erbB2
 /  or erbB2
 / 
mice. In explants derived from erbB2
 /  embryos there was
Figure 5. Failed rescue of O1  oligodendrocytes by addition of 
recombinant NRG. Spinal cord explants from E9.5 embryos were 
cultured for 10 d in the persistent presence or absence of 20 nM 
recombinant NRG-1. Supramaximal concentrations of NRG-1 are 
not sufficient to promote progression from proligodendrocyte to 
O1  oligodendrocyte in erbB2
 /  mutants. Comparisons by 
ANOVA showed statistical differences between erbB2
 /  and 
erbB2
 /  in both control (ctrl) and NRG treatment groups; 
P   0.0001 (indicated by asterisks). There was no statistical differ-
ence in erbB2
 /  explants between control and NRG treatment.
Table I. Percentage of cells with pyknotic nuclei for O4  and
O1  oligodendrocytes
O4  O1 
%%
ErbB2
 /  1.7 3.5
ErbB2
 /  1.5 2.7
ErbB2
 /  1.5 2.7
The number of O4  or O1  oligodendrocytes with pyknotic nuclei were
counted and expressed as the percentage of the total number of O4  or
O1  oligodendrocytes per explant. ANOVA revealed no statistical
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no significant increase in the number of O1  oligodendro-
cytes in explants grown in the presence of LIF compared
with controls. Together, the absence of increase in cell death
and the failure of known survival factors to compensate for
the lack of erbB2 signaling suggest that erbB2 transduces an
essential signal for terminal differentiation of oligodendro-
cytes rather than for their survival.
Deficient development of O1  oligodendrocytes in low 
density cultures from erbB2
 /  spinal cord explants
Although the above data are consistent with a cell autono-
mous function of erbB2 in oligodendrocyte development,
they do not distinguish cell-autonomous from cell-extrinsic
effects. To reduce the relative contribution of factors se-
creted by other cell types that might influence oligodendro-
cyte development, we generated low-density cell cultures (fi-
nal density  120 cells/cm
2) from spinal cord explants that
were enriched for oligodendrocytes (see Materials and meth-
ods). Cultures were then studied for development of
O1  oligodendrocytes. Morphologically, cultures contained
 60–70% cells of the oligodendrocyte lineage. In the pres-
ence of erbB2 (erbB2
 /  and erbB2
 / ) there were  5
O1  oligodendrocytes per well. In contrast, in the absence
of erbB2, O1  oligodendrocytes averaged less than 1 cell/
Figure 6. Lack of erbB2 signaling does 
not result in increased cell death of 
OPCs or oligodendrocytes in spinal 
cord explants. Spinal cord explants from 
erbB2
 / , erbB2
 / , and erbB2
 /  E9.5 
mouse embryos were cultured for 9 d 
and double-labeled with propidium 
iodide, and the stage-specific markers 
O4 (A) or O1 (B) and the number of 
apoptotic cells identified by nuclear 
pyknosis. (A) Explants from all three 
genotypes contain similar numbers of 
O4  cells, and a similar proportion of 
labeled cells had pyknotic nuclei. 
(B) Explants derived from knockout 
animals contain dramatically decreased 
numbers of O1  oligodendrocytes 
compared with hets and wild-type–
derived explants. The proportion of 
O1  cells with pyknotic nuclei is not 
different between explants derived from 
embryos of different genotypes. (C) 
Examples of O4  and 01  cells with 
characteristic pyknotic nuclei (arrows) in 
explant cultures derived from wild-type 
and erbB2
 /  embryos. These fields 
were selected because they contained 
pyknotic cells of the oligodendrocyte 
lineage and are not representative of the 
whole culture. Most fields show no 
apoptotic oligodendrocytes. As a 
positive control for detecting changes in 
nuclear morphology consistent with cell 
death, wild-type cultures were treated 
overnight with camptothecin (10  M) as 
described in Materials and methods. In 
camptothecin-treated cultures, numer-
ous oligodendrocytes with pyknotic 
nuclei can be identified (arrows). 
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well (Fig. 8). Although these results do not prove a cell au-
tonomous effect of erbB2 on oligodendrocyte development,
they reduce the likelihood that erbB2 is influencing oligo-
dendrocyte development by an extrinsic mechanism.
Ensheathment of neurites by oligodendrocytes is 
deficient in the absence of erbB2
The final stages of oligodendrocyte maturation involve spi-
raling of the leading edge of an oligodendrocyte process
around an axon to form the myelin internode. Since erbB2
appears important in the later stages of oligodendrocyte lin-
eage development, its requirement in the ensheathment of
neurites was examined. The small number of oligodendro-
cytes that differentiated to maturity in erbB2
 /  mutant ex-
plants allowed analyses of myelination in long-term explant
cultures. Explants from E9.5 wild-type, erbB2
 / , and
erbB2
 /  embryos were grown for 27–30 d under myelinat-
ing conditions and segments resembling internodes were
identified morphologically by labeling for MBP. Since only
small numbers of oligodendrocytes differentiate in erbB2
 / 
explants, the number of separate experiments was increased
to enhance data significance. In wild-type and erbB2
 /  ex-
plant cultures, numerous MBP  segments surrounding
neurites (Fig. 9) developed in all explants. By contrast, al-
though some MBP  oligodendrocytes were detectable in
explants derived from embryos lacking erbB2, and these cells
did extend processes that contacted neurites, they failed to
form MBP  segments surrounding neurites (Fig. 9). The
absence of MBP  segments in the erbB2
 /  explants was
not simply related to the reduction in terminally differenti-
ated oligodendrocytes, since wild-type and erbB2
 /  ex-
plants generate  2–3 internode-like segments per oligoden-
Figure 7. Ligands that transduce survival signals to oligodendro-
cytes through distinct transmembrane receptors do not rescue the 
erbB2
 /  phenotype. (A) PDGF-AA does not rescue GalC  oligo-
dendrocytes in erbB2 loss-of-function mutants. Similar to the results 
with exogenous NRG, addition of recombinant PDGF was unable to 
induce GalC  oligodendrocytes in erbB2
 /  explants. By ANOVA, 
there was a statistical difference between erbB2
 /  and erbB2
 / , 
P   0.0001 (indicated by asterisks), but not between control and 
PDGF treatment for erbB2
 /  explants. (B) LIF does not rescue the 
GalC  oligodendrocytes in the erbB2 loss-of-function mutants. 
By ANOVA, there was a statistical difference (P   0.0001) between 
control and LIF treatment groups for the erbB2
 /  and the erbB2
 /  
genotypes. In addition there was a statistical difference in the num-
ber of GalC  (O1 ) oligodendrocytes between erbB2
 /  and the 
erbB2
 /  or erbB2
 /  genotypes regardless of LIF treatment. There 
was no statistical difference between control and LIF treatment in 
the erbB2
 /  genotype group (P   0.4).
Figure 8. Low-density cultures from erbB2
 /  explants have 
significantly decreased numbers of O1  oligodendrocytes 
compared with cells expressing erbB2. Spinal cord explants from 
E9.5 mouse embryos (erbB2
 / , n   8; erbB2
 / , n   17; erbB2
 / , 
n   6) were cultured for 8 d in 24-well plates then rotated overnight 
at 200 rpm. Supernatants containing dislodged cells were plated in 
8-well chamber slides and cultured for 4 d in the presence of PDGF 
and bFGF. The medium was then changed to DME with N2 
additives, PDGF (0.5 ng/ml), and 1% FBS for an additional 36 h 
before immunostaining with the O1 mAb. (A) There is a significant 
(P   0.047 for erbB2
 / , erbB2
 /  comparison, and P   0.036 for 
erbB2
 / , erbB2
 /  comparison) reduction in the number of O1  
oligodendrocytes in the absence of erbB2. (B) Morphology of O1  
oligodendrocytes in low density culture. O1  oligodendrocytes ex-
pressing erbB2 have large lamellipodia, characteristic of differenti-
ated oligodendrocytes. In contrast, O1  oligodendrocytes from 
erbB2
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drocyte, and in erbB2
 /  explants, based on the number of
differentiated oligodendrocytes, 40–60 MBP  segments per
explant would have been expected.
Together, these data suggest that signals transduced through
the erbB2 receptor are required at distinct stages during the
development of the spinal cord oligodendrocyte lineage.
In the absence of erbB2 there is a dramatic reduction in
the number of terminally differentiated oligodendrocytes.
ErbB2
 /  oligodendrocytes that do develop fail to ensheath
neurites, consistent with the notion that myelination in the
central nervous system (CNS) requires a signal, presumably
axonal in origin, that activates erbB2 in oligodendrocytes.
Discussion
There is an absolute requirement for NRG-1 in the forma-
tion of O4  proligodendroblasts in cultures of murine spi-
nal cord (Vartanian et al., 1999). Here we show that spinal
cord oligodendrocytes and OPCs express erbB2, erbB3, and
erbB4, and also examine the function of erbB2 in spinal
cord oligodendrocyte development and myelination. In
striking contrast to the lack of spinal cord oligodendrocyte
precursor development in the absence of NRG-1 (Vartanian
et al., 1999), O4  proligodendroblasts develop normally in
the absence of erbB2. Wild-type and erbB2
 /  spinal cord
explants develop abundant numbers of differentiated O1 
oligodendrocytes, whereas in erbB2
 /  spinal cord explants,
development is halted at the proligodendroblast stage and
very few O1  oligodendrocytes develop. Similarly, in wild-
type and erbB2
 /  explants MBP  oligodendrocytes are
abundant, whereas erbB2
 /  explants contained relatively
few mature MBP  oligodendrocytes. Finally, wild-type or
erbB2
 /  oligodendrocytes generate numerous initiator pro-
cesses and ensheathment tubes as described previously
(Hardy and Friedrich, 1996). By contrast, although neurite
and astrocyte development appear normal in erbB2
 /  ex-
plants, myelination is completely absent in erbB2
 /  ex-
plants. ErbB2
 /  oligodendrocytes contact neurites, but do
not form initiator processes or ensheathment tubes, suggest-
ing a critical role for erbB2 signaling in axonal ensheathment
and myelination.
NRG-mediated signals transduced through diverse 
erbB receptors are required for distinct stages in 
oligodendrocyte development
Although the precise function of NRGs during the early de-
velopment of OPCs is unclear, during later stages of oligo-
dendrocyte development there is a clear role for NRG medi-
ated signals. NRGs appear to be required for the survival of
established OPCs (Fernandez et al., 2000; Flores et al.,
2000). In spinal cord explants grown in the presence of a
soluble inhibitor of NRG, O4  proligodendroblasts do not
develop (Vartanian et al., 1999). Similarly, O4  proligo-
dendroblasts do not develop in spinal cord explants from
NRG-1–deficient mice, and this can be reversed by the ad-
dition of recombinant NRG-1 (Vartanian et al., 1999). It
was thus surprising that in the erbB2 null mouse there is
normal development of O4  proligodendroblasts in ex-
plants derived from erbB2 null embryos. These findings sug-
gest that in oligodendrocyte lineage cells expressing erbB2,
Figure 9. Deficient axonal ensheathment in erbB2 loss-of-function 
mutants. Spinal cord explants derived from erbB2
 /  and erbB2
 /  
mice at E9.5 were cultured for 30 d and then double-labeled for NF 
and MBP. Single exposures for NF (green), MBP (red), and double 
exposures for NF/MBP are shown. (A) In spinal cord explants from 
erbB2
 /  mice, some oligodendrocytes mature to the MBP  stage. 
However, even when surrounded by neurites, these cells fail to 
ensheath neurites or form internodes morphologically. (B) Spinal 
cord explants from erbB2
 /  mice show numerous myelin 
internodes morphologically. The cell body of the oligodendrocyte 
from which this cluster of internodes is derived is only faintly visi-
ble, since immunoreactivity to MBP after myelination is diminished 
in the soma and restricted to internodes. (C) Quantitation of the 
number of myelin internodes per explant from erbB2
 / , erbB2
 / , 
and erbB2
 /  mice. In the presence of erbB2, numerous myelin 
internodes are identified, whereas in the absence of erbB2, none 
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erbB3, and erbB4, signals derived from the erbB2 cytosolic
domain are not essential for the generation of the lineage be-
fore the appearance of O4  proligodendroblasts. Similarly,
the normal development of O4  proligodendroblasts in
erbB2
 /  explants suggests that NRG receptors other than
erbB2 are capable of transducing the signals necessary for the
formation of these cells. Signals transduced by erbB2 do ap-
pear to be essential for the appearance of differentiated O1 
oligodendrocytes, however, since these cells fail to develop in
erbB2
 /  explants despite the presence of high concentra-
tions of insulin, PDGF-AA, or LIF. These observations
strongly suggest that erbB2 transduces a distinct signal re-
quired for the appearance of terminal-differentiated oligo-
dendrocytes and myelination.
The ability of individual erbB receptors to transduce dis-
tinct intracellular signals is well established in transformed
cell lines (for review see Pinkas-Kramarski et al., 1998; Riese
and Stern, 1998; Yarden and Sliwkowski, 2001). For exam-
ple, the cellular response, patterns of receptor phosphoryla-
tion, and recruitment of intracellular signaling proteins varies
between erbB4 homodimers stimulated with different NRGs
(Sweeney et al., 2000). Secondly, receptor usage is critically
important to signal diversification (Pinkas-Kramarski et al.,
1996). There is evidence that individual class I receptors
transduce overlapping and nonoverlapping intracellular sig-
nals. For example, analyses of the potential SH2 docking sites
on erbB receptors demonstrated both unique as well as ho-
mologous sites, indicating the potential for overlapping and
nonoverlapping signaling through individual receptors (Carr-
away and Cantley, 1994). Furthermore, in addition to trans-
ducing signals common to other erbB receptors, erbB4 ap-
pears to activate distinct signaling pathways (Jones et al.,
1999; Zhao et al., 1999; Huang et al., 2000). In conjunction
with our previous results, the current data from the erbB2
 / 
mouse shows that in primary cells, the NRG receptor erbB2
is likely transducing distinct intracellular signals necessary for
the appearance of differentiated oligodendrocytes.
Several lines of evidence suggest that the signaling through
the erbB2 receptor mediates a differentiation rather than
survival signal for emerging oligodendrocytes. For example,
there is no apparent increase in cell death in the oligoden-
drocyte lineage in the absence of erbB2 signaling and addi-
tion of known growth/survival factors fails to reverse this
cellular phenotype. It remains possible that interactions be-
tween different classes of receptors are required for the dif-
ferentiation of oligodendrocytes. The inability of LIF to en-
hance survival of erbB2
 /  oligodendrocytes may reflect
interactions between erbB2 and the LIF receptor gp130. In
prostate cancer cells overexpressing erbB2, IL-6 induces a
ligand-dependent association of erbB2 with the gp130 com-
ponent of the IL-6 receptor and is required for mitogen-acti-
vated protein kinase activation by IL-6 (Qiu et al., 1998).
The current work does not exclude such a possibility. Fur-
thermore, although it seems likely that the lack of differenti-
ated oligodendrocytes in erbB2
 / -derived explants reflects
cell-intrinsic signaling in OPCs, astrocytes and neurons ex-
press NRG receptors and the effects on oligodendrocyte de-
velopment may result from an erbB2-regulated synthesis of
an inhibitor of oligodendrocyte differentiation in these other
cell types.
Axonally derived signals are necessary for 
oligodendrocyte development and myelination
By the time OPCs populate white matter tracts axonogenesis
is completed, and thus oligodendrocyte differentiation and
myelination follow axonogenesis. This timing is consistent
with the inhibitory influence of CNS myelin on axonal
growth (Filbin et al., 1990; Bandtlow and Schwab, 2000;
Chen et al., 2000; GrandPre et al., 2000). The critical im-
portance of axonal-derived signaling at multiple stages of
oligodendrocyte development is inferred from several ex-
perimental studies. During development, oligodendrocyte
numbers are closely matched to the number of axons. In-
creasing axon numbers increases the number of OPCs in
parallel (Burne et al., 1996). Removal of axons by neonatal
enucleation or optic nerve transection (Fulcrand and Privat,
1977; Privat et al., 1981; David et al., 1984; Valat et al.,
1988; Ueda et al., 1999) significantly reduces the number of
optic nerve oligodendrocytes; although, some develop nor-
mally in the absence of axons (Ueda et al., 1999) as they do
in the absence of erbB2. Thus, in neonatal mammals, axonal
signals appear to induce proliferation of OPCs and survival
of oligodendrocytes (Fulcrand and Privat, 1977; Privat et al.,
1981; David et al., 1984; Valat et al., 1988; Barres et al.,
1992a; Barres and Raff, 1993). In the postnatal and adult
mammalian CNS, however, axonal signals appear to serve a
different purpose. Specific signals from the axon are required
for myelination since other elements such as dendrites do
not undergo myelination (Lubetzki et al., 1993). In the
adult, axotomy or neurectomy results in axonal degeneration
and concomitant myelin degradation in the absence of sig-
nificant oligodendrocyte apoptosis (Fulcrand and Privat,
1977; Stoll et al., 1989; Wisniewski, 1983; Butt and Kirvell,
1996). The physical presence of axons is sufficient to main-
tain myelin internodes. In the C57BL/Ola mouse, a sponta-
neously occurring mutant with abnormally prolonged Wal-
lerian degeneration (Brown et al., 1991; Ludwin and Bisby,
1992), distal axonal segments, and oligodendrocyte-myelin
units remain intact for up to 4 wk after axotomy or transec-
tion compared with 1–2 d for normal controls (Ludwin and
Bisby, 1992). The ability of a distal, posttransection axonal
segment to provide trophic influences is not limited to oli-
godendrocytes and Schwann cells. The neuromuscular junc-
tion, which also requires axonal-derived NRG for its devel-
opment (Fischbach and Rosen, 1997; Sandrock et al., 1997;
Fromm and Burden, 1998; Wolpowitz et al., 2000), is also
maintained for prolonged periods of time after transection
in the C57BL/Ola mouse (Ribchester et al., 1995).
At least two candidate molecules have been described that
might mediate the axonally derived signals which influence
oligodendrocyte development: Jagged1 and NRG. Jagged1
acting through Notch receptors on OPCs is a potent inhibi-
tor of oligodendrocyte differentiation in the optic nerve
(Wang et al., 1998b). Jagged1 is expressed on axons and its
levels fall as myelination proceeds, suggesting it may be an
important signal inhibiting differentiation or myelination
until the appropriate developmental stage. Therefore, it is
possible that the defect in terminal differentiation of oligo-
dendrocytes in the absence of erbB2 could be the conse-
quence of up-regulation of Jagged1 or related ligands in spi-
nal cord neurons.ErbB2 is essential in oligodendrocyte development | Park et al. 1255
NRG is a candidate axonal signal for oligodendrocyte 
formation and myelination
In the developing nervous system, NRG is localized to neu-
rons and axons (Corfas et al., 1995; Dong et al., 1995; Jo et
al., 1995; Sandrock et al., 1995; Trachtenberg and Thomp-
son, 1996; Loeb et al., 1998) as well as floor plate structures
in early CNS development (Corfas et al., 1995; Vartanian et
al., 1994, 1999). In vitro studies demonstrate that axonally
derived NRG in its membrane-associated form is capable of
activating erbB receptors (Vartanian et al., 1997), indicating
that axonally associated NRG can mediate its effects as a
consequence of direct axonal–glial interactions.
In the PNS, NRG plays multiple distinct roles in
Schwann cell development. Early in development, NRG in-
duces a glial fate in neural crest precursors (Shah et al.,
1994). In committed Schwann cell precursors axonally de-
rived NRG serves as a survival factor (Dong et al., 1995). In
mature Schwann cells axonally derived NRG is responsible
for all or most of the survival and mitogenic effects of axons
on the Schwann cell lineage. For example, antibodies to
erbB2 inhibit axon-induced proliferation of Schwann cells
(Morrissey et al., 1995). Similarly, addition of exogenous
NRG markedly reduced Schwann cell apoptosis during nor-
mal development or as the consequence of axotomy (Grin-
span et al., 1996; Trachtenberg and Thompson, 1996). Fur-
thermore, in mice bearing mutations in NRG-1 or the NRG
receptors erbB2 and erbB3, there is a profound reduction in
the number of Schwann cells (Lee et al., 1995; Meyer and
Birchmeier, 1995; Erickson et al., 1997; Riethmacher et al.,
1997; Morris et al., 1999), as well as effects on axonal fascic-
ulation and target finding (Morris et al., 1999; Wolpowitz et
al., 2000). A conditional erbB2 mutation in promyelinating
and myelinating Schwann cells results in diminished PNS
myelination (Garratt et al., 2000).
Likewise, our data suggest that in the CNS, NRG plays
multiple distinct roles in oligodendrocyte development which
are mediated by distinct erbB receptors. NRG, possibly de-
rived from ventral midline structures, but not the erbB2 re-
ceptor, is required for oligodendrocyte precursors to develop
to O4  cells (Vartanian et al., 1999). NRG, possibly derived
from axons, and the erbB2 receptor are required for differen-
tiation of O4  precursors to oligodendrocytes and subse-
quent steps in myelination. Although the requirement of
erbB2 in oligodendrocyte development and ensheathment of
axons may be cell autonomous, it remains possible that muta-
tions of erbB2 influence oligodendrocyte development indi-
rectly through effects on neurons or astrocytes.
Materials and methods
Targeted disruption of the murine erbB2 gene
For targeted mutation of the murine erbB2 gene, a 129/SvJ genomic DNA
library was screened with a full-length erbB2-specific probe. Two overlap-
ping clones of  15–16 kb in length were obtained (l13 and l21). A 9-kb
NotI-XhoI fragment of clone l13 was inserted 5  of the neomycin resistance
cassette of the pPNT vector, and an 800 bp BamHI-EcoRI fragment was
placed on the 3  side of the neo
r cassette. This construct removes from the
erbB2 gene a 2–3-kb genomic fragment containing the exon encoding the
essential transmembrane domain of the erbB2 receptor protein as well as
flanking sequences encoding parts of the extracellular and cytoplasmic do-
mains. After electroporation of ES cells with the linearized construct and
double selection with G418 and FIAU, resistant clones were studied by
Southern analysis using a 500 bp 3  fragment of the genomic clone not in-
corporated in the targeting vector. A clone bearing the disrupted gene was
injected into C57BL/6 blastocysts and several resulting chimeric animals
were obtained. These animals carried the disrupted allele and were able to
pass it through the germ line. Homozygous null mutants fail to develop
past 11.5 dpc and express no full-length protein by Western blot analysis.
Heterozygous animals develop normally and express about half the wild-
type amount of erbB2 protein.
ErbB2 null mice and spinal cord explants
To generate erbB2
 / , erbB2
 / , and erbB2
 /  embryos, litters were ob-
tained from timed pregnancies of erbB2
 /  female and erbB2
 /  male mat-
ings 9.5 dpc. Each embryo was given a code number and spinal cords
were dissected out and cut transversely into 1–2-mm fragments for explant
culture onto polylysine and laminin-coated coverslips in DME, N2 addi-
tives, and 2% FBS. The remainder of each embryo was used to isolate ge-
nomic DNA for Southern blot analysis. To study myelination in vitro, me-
dium containing N2 additives, 0.5 ng/ml PDGF-AA, and 2% FBS was used.
These are conditions that we have previously determined to be optimal for
myelination in spinal cord cultures.
To generate purified populations of OPCs and oligodendrocytes, cells
were immunopanned from newborn rat spinal cord using mAbs A2B5, O4,
or O1, respectively, as described previously (Robinson et al., 1998). Purity
of the cell population was assayed on a separate cell aliquot 12 h after
panning, and in all cases was  98% pure panned cells. Samples were
snap frozen in liquid nitrogen and stored at  70 C until use.
Low-density cultures of enriched oligodendrocytes were generated as
follows. Spinal cord explants from E9.5 mice were cultured in poly-L-orni-
thine–coated 24-well plates with a single explant per well. After 8 d in
vitro, the medium was changed to DME with N2 additives and 20% FBS
and the plates were rotated for 16 h at 200 rpm at 37 C. Supernatants from
individual explants were plated into individual wells of 8-well Permanox
chamber slides (Nunc). After 2 h, the majority of cells adhered and the me-
dium was replaced with DME containing N2 additives, 0.5 ng/ml PDGF-
AA, and 1% FBS. OPCs were briefly expanded with PDGF (10 ng/ml) and
bFGF (10 ng/ml) for 4 d, then switched to medium containing N2 addi-
tives, 0.5 ng/ml PDGF, and 1% FBS for an additional 36 h, then immu-
nostained for surface galctocerebroside with the mAb O1. After fixation
the cell density was determined by cell counts and averaged  120 cells/
cm
2. Approximately 60% of the cells were morphologically within the oli-
godendrocyte lineage. The remaining cells were morphologically astro-
cytes and fibroblasts. No neurons were observed.
Immunofluorescence microscopy
For A2B5, O4, or O1 immunofluorescence, live explant cultures were incu-
bated for 15 min with the relevant mAb, washed with PBS, then fixed in
fresh 4% paraformaldehyde in PBS for 7 min at ambient temperature,
washed with PBS, then incubated with the relevant secondary antibody
(Jackson ImmunoResearch Laboratories) and visualized by epifluorescence.
For NF and GFAP immunofluorescence, cells were treated with 0.125%
Triton X-100 in PBS for 20 min before incubation with primary antibody.
For MBP staining, after fixation with paraformaldehyde, cells were perme-
abilized with ice-cold methanol for 10 min before incubation with primary
antibody. Primary antibodies used were against the following: A2B5, O4,
and O1 (American Type Culture Collection), MBP SMI99 (Sternberger
Monoclonals, Inc.), NF 200 kD (Roche and Sigma-Aldrich), GFAP (Roche),
erbB2 and erbB3 (Upstate Biotechnology), erbB4 (Santa Cruz Biotechnol-
ogy, Inc.). Immunofluorescent images were obtained using a Nikon Eclipse
660 microscope with 20, 40, and 60  objectives, exposing 400 ASA Kodak
color 35-mm film, images were then digitized using a slide scanner.
Cell counts
In wild-type and erbB2
 /  explants (after unblinding), O4  and O1  oli-
godendrocytes were dense within the explant itself and thus difficult to
count with any certainty. Thus, for wild-type and erbB2
 /  explants, the
outgrowth was counted. In erbB2
 /  explants, there are so few O1  oligo-
dendrocytes that the occasional O1  cell within the explant is easily iden-
tified and can be counted. Thus, we included O1  cells within the explant
for the erbB2
 /  explants, but excluded them in the erbB2
 /  and erbB2
 / 
explants. Thus, the results were biased against the observed difference.
There were so few O1  oligodendrocytes within the erbB2
 /  explants
(1–2 of 20–30) that the results did not statistically differ whether or not
they were included in the analysis.
Viability studies
To assess cell death of oligodendrocytes (O1  and O4 ) in the presence
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with O4 or O1 mAbs, fixed with 95% ethanol/5% glacial acetic acid for 1
min, incubated with FITC goat anti–mouse IgM (  chain specific), and
stained with propidium iodide (20 mg/ml) for 5 min. The total number of
O4  or O1  oligodendrocytes and the number of O4  or O1  oligo-
dendrocytes showing pyknotic nuclei were counted by epifluorescence
microscopy. Camptothecin was used at the concentration of 10  M over-
night to induce cell death. Camptothecin is a cytotoxic plant alkaloid that
induces DNA damage by inhibiting the activity of DNA topoisomerase-I
(Morris and Geller, 1996).
RT-PCR of messages encoding erbB receptors
Total RNA was isolated from rat OPCs (A2B5) and oligodendrocytes
(O4 ) by using Trizol Reagent (Life Technologies). Complementary DNA
(cDNA) was synthesized from total RNA with oligo(dT) primers and Super-
Script II reverse transcriptase (Life Technologies) according to the manu-
facturer’s protocol. A specific cDNA fragment was amplified by Platinum
TagPCRx DNA polymerase (Life Technologies) using specific primers for
erbB2, erbB3, or erbB4 (36 cycles of 94 C for 2 min, 58 C for 1 min and
72 C for 2 min, and a final 10 min 72 C extension). Amplified sequences
by PCR were the regions corresponding to nucleotides 1726–2133 (408
bp) of the rat erbB2 mRNA sequences (EMBL/GenBank/DDBJ accession
no. NM_017003), nucleotides 3606–4002 (397 bp) of the rat erbB3 mRNA
sequences (EMBL/GenBank/DDBJ accession no. NM_017218), and nucle-
otides 1891–2058 of the rat erbB4 mRNA sequences (EMBL/GenBank/
DDBJ accession no. AF041838). Primers for PCR were: erbB2 sense 5 -
CGAGTGTCAGCCTCAAAACA-3 , antisense 5 -GTCAGCGGCTCCAC-
TAACTC-3 ; erbB3 sense 5 -CGTCATGCCAGATACACACC-3 , antisense
5 -CTCCTCGTACCCTTGCTCAG-3 ; and erbB4 sense 5 -AACTGCAC-
CCAGGGGTGTAA-3 , antisense 5 -GACATAAACGGCAAATGTCA-3 .
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